WAAG
TMO icon

Wealth Alliance Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Wealth Alliance Advisory Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$564K Sell
1,125
-100
-8% -$48K 0.08% 112
2026
Q1 		$602K Buy
1,225
+103
+9% +$55.9K 0.1% 108
2025
Q4 		$650K Hold
1,122
– – 0.11% 104
2025
Q3 		$544K Hold
1,122
– – 0.1% 106
2025
Q2 		$455K Sell
1,122
-793
-41% -$332K 0.09% 118
2025
Q1 		$953K Buy
1,915
+813
+74% +$440K 0.2% 76
2024
Q4 		$573K Sell
1,102
-39
-3% -$21.4K 0.12% 97
2024
Q3 		$706K Hold
1,141
– – 0.15% 92
2024
Q2 		$631K Sell
1,141
-46
-4% -$26.4K 0.14% 91
2024
Q1 		$690K Sell
1,187
-8
-0.7% -$4.49K 0.16% 84
2023
Q4 		$634K Hold
1,195
– – 0.17% 81
2023
Q3 		$605K Sell
1,195
-32
-3% -$17.1K 0.18% 77
2023
Q2 		$640K Buy
1,227
+69
+6% +$37.2K 0.23% 70
2023
Q1 		$667K Hold
1,158
– – 0.25% 66
2022
Q4 		$638K Buy
1,158
+96
+9% +$50.9K 0.24% 65
2022
Q3 		$539K Hold
1,062
– – 0.24% 68
2022
Q2 		$577K Hold
1,062
– – 0.27% 63
2022
Q1 		$627K Sell
1,062
-631
-37% -$362K 0.27% 64
2021
Q4 		$1.13M Buy
1,693
+149
+10% +$93K 0.49% 35
2021
Q3 		$882K Buy
1,544
+8
+0.5% +$4.39K 0.43% 43
2021
Q2 		$775K Buy
1,536
+20
+1% +$9.44K 0.38% 51
2021
Q1 		$692K Buy
1,516
+447
+42% +$213K 0.35% 54
2020
Q4 		$498K Sell
1,069
-4
-0.4% -$1.88K 0.27% 61
2020
Q3 		$474K Sell
1,073
-3
-0.3% -$1.24K 0.28% 57
2020
Q2 		$390K Hold
1,076
– – 0.24% 65
2020
Q1 		$305K Sell
1,076
-12
-1% -$3.78K 0.24% 72
2019
Q4 		$353K Hold
1,088
– – 0.2% 79
2019
Q3 		$309K Sell
1,088
-8
-0.7% -$2.29K 0.19% 80
2019
Q2 		$317K Sell
1,096
-4
-0.4% -$1.1K 0.2% 81
2019
Q1 		$299K Buy
1,100
+56
+5% +$13.9K 0.19% 85
2018
Q4 		$234K Sell
1,044
-400
-28% -$93.8K 0.18% 96
2018
Q3 		$352K Sell
1,444
-3
-0.2% -$690 0.18% 89
2018
Q2 		$300K Buy
1,447
+15
+1% +$3.18K 0.16% 91
2018
Q1 		$296K Buy
+1,432
New +$301K 0.17% 82

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Wealth Alliance Advisory Group's TMO Position: Q2 2026 in Review

Wealth Alliance Advisory Group reduced its Thermo Fisher Scientific (TMO) stake by 8.2% in Q2 2026, selling an estimated $48K and leaving 1,125 shares worth $564K. The position accounts for 0.08% of the portfolio, ranked #112.

Wealth Alliance Advisory Group first reported a position in TMO in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.13M in Q4 2021. 1,170 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wealth Alliance Advisory Group held 1,125 shares of Thermo Fisher Scientific worth $564K as of Q2 2026.
  • Wealth Alliance Advisory Group sold 100 Thermo Fisher Scientific shares in Q2 2026, an estimated $48K.
  • Thermo Fisher Scientific made up 0.08% of Wealth Alliance Advisory Group's portfolio in Q2 2026, its #112 holding.
  • Wealth Alliance Advisory Group first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 34 quarters since.
  • Wealth Alliance Advisory Group's Thermo Fisher Scientific position peaked at $1.13M in Q4 2021.
  • 1,170 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wealth Alliance Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.